Literature DB >> 10805796

Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity.

D Gisselsson1, L Pettersson, M Höglund, M Heidenblad, L Gorunova, J Wiegant, F Mertens, P Dal Cin, F Mitelman, N Mandahl.   

Abstract

It has long been known that rearrangements of chromosomes through breakage-fusion-bridge (BFB) cycles may cause variability of phenotypic and genetic traits within a cell population. Because intercellular heterogeneity is often found in neoplastic tissues, we investigated the occurrence of BFB events in human solid tumors. Evidence of frequent BFB events was found in malignancies that showed unspecific chromosome aberrations, including ring chromosomes, dicentric chromosomes, and telomeric associations, as well as extensive intratumor heterogeneity in the pattern of structural changes but not in tumors with tumor-specific aberrations and low variability. Fluorescence in situ hybridization analysis demonstrated that chromosomes participating in anaphase bridge formation were involved in a significantly higher number of structural aberrations than other chromosomes. Tumors with BFB events showed a decreased elimination rate of unstable chromosome aberrations after irradiation compared with normal cells and other tumor cells. This result suggests that a combination of mitotically unstable chromosomes and an elevated tolerance to chromosomal damage leads to constant genomic reorganization in many malignancies, thereby providing a flexible genetic system for clonal evolution and progression.

Entities:  

Mesh:

Year:  2000        PMID: 10805796      PMCID: PMC25833          DOI: 10.1073/pnas.090013497

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

Review 1.  ATM: a mediator of multiple responses to genotoxic stress.

Authors:  G Rotman; Y Shiloh
Journal:  Oncogene       Date:  1999-11-01       Impact factor: 9.867

2.  The Stability of Broken Ends of Chromosomes in Zea Mays.

Authors:  B McClintock
Journal:  Genetics       Date:  1941-03       Impact factor: 4.562

3.  Transmission of radiation-induced rearrangements through cell divisions.

Authors:  W Al-Achkar; L Sabatier; B Dutrillaux
Journal:  Mutat Res       Date:  1988-03       Impact factor: 2.433

4.  Duplication of ATR inhibits MyoD, induces aneuploidy and eliminates radiation-induced G1 arrest.

Authors:  L Smith; S J Liu; L Goodrich; D Jacobson; C Degnin; N Bentley; A Carr; G Flaggs; K Keegan; M Hoekstra; M J Thayer
Journal:  Nat Genet       Date:  1998-05       Impact factor: 38.330

5.  Massive cytogenetic heterogeneity in a pancreatic carcinoma: fifty-four karyotypically unrelated clones.

Authors:  L Gorunova; B Johansson; S Dawiskiba; A Andrén-Sandberg; Y Jin; N Mandahl; S Heim; F Mitelman
Journal:  Genes Chromosomes Cancer       Date:  1995-12       Impact factor: 5.006

6.  The structure and dynamics of ring chromosomes in human neoplastic and non-neoplastic cells.

Authors:  D Gisselsson; M Höglund; F Mertens; B Johansson; P Dal Cin; H Van den Berghe; W C Earnshaw; F Mitelman; N Mandahl
Journal:  Hum Genet       Date:  1999-04       Impact factor: 4.132

7.  Genetic instability induced by the tumor microenvironment.

Authors:  T Y Reynolds; S Rockwell; P M Glazer
Journal:  Cancer Res       Date:  1996-12-15       Impact factor: 12.701

8.  Consistent chromosome abnormalities in adenocarcinoma of the pancreas.

Authors:  C A Griffin; R H Hruban; L A Morsberger; T Ellingham; P P Long; E M Jaffee; K M Hauda; S K Bohlander; C J Yeo
Journal:  Cancer Res       Date:  1995-06-01       Impact factor: 12.701

9.  Characterization of the CHOP breakpoints and fusion transcripts in myxoid liposarcomas with the 12;16 translocation.

Authors:  I Panagopoulos; N Mandahl; D Ron; M Höglund; M Nilbert; F Mertens; F Mitelman; P Aman
Journal:  Cancer Res       Date:  1994-12-15       Impact factor: 12.701

10.  Three major cytogenetic subgroups can be identified among chromosomally abnormal solitary lipomas.

Authors:  N Mandahl; S Heim; K Arheden; A Rydholm; H Willén; F Mitelman
Journal:  Hum Genet       Date:  1988-07       Impact factor: 4.132

View more
  110 in total

1.  How do tumors make ends meet?

Authors:  C Lengauer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

2.  Low molecular weight cyclin E overexpression shortens mitosis, leading to chromosome missegregation and centrosome amplification.

Authors:  Rozita Bagheri-Yarmand; Anna Biernacka; Kelly K Hunt; Khandan Keyomarsi
Journal:  Cancer Res       Date:  2010-06-08       Impact factor: 12.701

3.  Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells.

Authors:  Gabriel Cuevas-Ramos; Claude R Petit; Ingrid Marcq; Michèle Boury; Eric Oswald; Jean-Philippe Nougayrède
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

Review 4.  Chromosomes and cancer cells.

Authors:  Sarah L Thompson; Duane A Compton
Journal:  Chromosome Res       Date:  2011-04       Impact factor: 5.239

Review 5.  Cancer chromosomal instability: therapeutic and diagnostic challenges.

Authors:  Nicholas McGranahan; Rebecca A Burrell; David Endesfelder; Marco R Novelli; Charles Swanton
Journal:  EMBO Rep       Date:  2012-06-01       Impact factor: 8.807

6.  Cycles of chromosome instability are associated with a fragile site and are increased by defects in DNA replication and checkpoint controls in yeast.

Authors:  Anthony Admire; Lisa Shanks; Nicole Danzl; Mei Wang; Ulli Weier; William Stevens; Elizabeth Hunt; Ted Weinert
Journal:  Genes Dev       Date:  2005-12-29       Impact factor: 11.361

7.  HTLV-1 propels untransformed CD4 lymphocytes into the cell cycle while protecting CD8 cells from death.

Authors:  David Sibon; Anne-Sophie Gabet; Marc Zandecki; Christiane Pinatel; Julien Thête; Marie-Hélène Delfau-Larue; Samira Rabaaoui; Antoine Gessain; Olivier Gout; Steven Jacobson; Franck Mortreux; Eric Wattel
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

Review 8.  Mechanisms of tumor resistance to EGFR-targeted therapies.

Authors:  Elizabeth A Hopper-Borge; Rochelle E Nasto; Vladimir Ratushny; Louis M Weiner; Erica A Golemis; Igor Astsaturov
Journal:  Expert Opin Ther Targets       Date:  2009-03       Impact factor: 6.902

9.  Chromosomal heterogeneity and instability characterize pediatric medulloblastoma cell lines and affect neoplastic phenotype.

Authors:  Angel Mauricio Castro-Gamero; Kleiton Silva Borges; Regia Caroline Lira; Augusto Faria Andrade; Paola Fernanda Fedatto; Gustavo Alencastro Veiga Cruzeiro; Ricardo Bonfim Silva; Aparecida Maria Fontes; Elvis Terci Valera; Michael Bobola; Carlos Alberto Scrideli; Luiz Gonzaga Tone
Journal:  Cytotechnology       Date:  2013-01-17       Impact factor: 2.058

Review 10.  Chromosome therapy. Correction of large chromosomal aberrations by inducing ring chromosomes in induced pluripotent stem cells (iPSCs).

Authors:  Taehyun Kim; Marina Bershteyn; Anthony Wynshaw-Boris
Journal:  Nucleus       Date:  2014 Sep-Oct       Impact factor: 4.197

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.